HU218939B - 2,4-Dioxo-tieno[2,3-d]pirimidin-származékok, eljárás a vegyületek előállítására, valamint ezeket tartalmazó gyógyászati készítmények - Google Patents

2,4-Dioxo-tieno[2,3-d]pirimidin-származékok, eljárás a vegyületek előállítására, valamint ezeket tartalmazó gyógyászati készítmények Download PDF

Info

Publication number
HU218939B
HU218939B HU9402453A HU9402453A HU218939B HU 218939 B HU218939 B HU 218939B HU 9402453 A HU9402453 A HU 9402453A HU 9402453 A HU9402453 A HU 9402453A HU 218939 B HU218939 B HU 218939B
Authority
HU
Hungary
Prior art keywords
alkyl
alkoxy
phenyl
compound
methyl
Prior art date
Application number
HU9402453A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9402453D0 (en
HUT71116A (en
Inventor
Nobuo Choh
Shuichi Furuya
Tetsuya Ohtaki
Toshifumi Watanabe
Original Assignee
Takeda Chemical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd. filed Critical Takeda Chemical Industries Ltd.
Publication of HU9402453D0 publication Critical patent/HU9402453D0/hu
Publication of HUT71116A publication Critical patent/HUT71116A/hu
Publication of HU218939B publication Critical patent/HU218939B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU9402453A 1993-08-26 1994-08-25 2,4-Dioxo-tieno[2,3-d]pirimidin-származékok, eljárás a vegyületek előállítására, valamint ezeket tartalmazó gyógyászati készítmények HU218939B (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21197293 1993-08-26
JP14812694 1994-06-29

Publications (3)

Publication Number Publication Date
HU9402453D0 HU9402453D0 (en) 1994-10-28
HUT71116A HUT71116A (en) 1995-11-28
HU218939B true HU218939B (hu) 2001-01-29

Family

ID=26478451

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9402453A HU218939B (hu) 1993-08-26 1994-08-25 2,4-Dioxo-tieno[2,3-d]pirimidin-származékok, eljárás a vegyületek előállítására, valamint ezeket tartalmazó gyógyászati készítmények

Country Status (11)

Country Link
EP (1) EP0640606B1 (Direct)
KR (1) KR950005311A (Direct)
CN (1) CN1106663A (Direct)
AT (1) ATE208393T1 (Direct)
CA (1) CA2130859A1 (Direct)
DE (1) DE69428952T2 (Direct)
FI (2) FI943912L (Direct)
HU (1) HU218939B (Direct)
NO (1) NO307565B1 (Direct)
RU (1) RU2142275C1 (Direct)
TW (1) TW276256B (Direct)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140325A (en) * 1993-08-19 2000-10-31 Takeda Chemical Industries, Ltd. Thienopyrimidine derivatives, their production and use
US6048863A (en) 1994-04-19 2000-04-11 Takeda Chemical Industries, Ltd. Condensed-ring thiophene derivatives and thienopyrimidine derivatives, their production and use
UY23948A1 (es) * 1995-02-08 2001-10-25 Takeda Chemical Industries Ltd Derivados de anillos condensados de tiofeno su producción y uso.
EP0846119B1 (en) * 1995-08-17 2002-11-13 Takeda Chemical Industries, Ltd. Thienopyrimidine derivatives, their production and use as endothelin antagonists
CA2192283A1 (en) * 1995-12-08 1997-06-09 Nobuhiro Suzuki Prolactin production inhibitory agent
US5828149A (en) * 1996-07-18 1998-10-27 Baker Hughes Incorported Lubricant inducer pump for electrical motor
US6025371A (en) * 1996-10-28 2000-02-15 Versicor, Inc. Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones
US6413724B1 (en) 1996-10-28 2002-07-02 Versicor, Inc. Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones
AU6908398A (en) * 1996-10-28 1998-05-22 Versicor Inc Fused 2,4-pyrimidinedione combinatorial libraries and biologically active fused 2,4-pyramidinediones
SE9702001D0 (sv) * 1997-05-28 1997-05-28 Astra Pharma Prod Novel compounds
US6469014B1 (en) 1997-05-28 2002-10-22 Astrazeneca Ab Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy
US6984644B2 (en) 1997-05-28 2006-01-10 Astrazeneca Ab Treatment of skin disorders using thieno[2,3-D]pyrimidinediones
DE69912618T2 (de) * 1998-08-28 2004-10-28 Astrazeneca Ab NEUE THIENO[2,3-d]PYRIMIDINDIONE, VERFAHREN FÜR IHRE HERSTELLUNG UND IHRE VERWENDUNG IN DER THERAPIE
HN2000000051A (es) * 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
AU2001252825A1 (en) * 2000-05-04 2001-11-12 Astrazeneca Ab Thieno(2,3-d)pyrimidinediones and their use as pharmaceuticals
WO2002024703A1 (en) * 2000-09-22 2002-03-28 Akzo Nobel N.V. Bicyclic heteroaromatic compounds
RU2225866C1 (ru) * 2002-11-18 2004-03-20 Халиуллин Азат Наилевич Калиевая соль 2-[5(6)-нитро-1-(тиетанил-3)-бензимидазолил-2-тио]уксусной кислоты, проявляющая кардиотоническую активность
TWI582095B (zh) * 2011-11-11 2017-05-11 基利阿波羅有限責任公司 Ａｃｃ抑制劑及彼等之用途
CN102920695B (zh) * 2012-11-16 2014-08-06 蔡进 苯并呋喃类内皮素受体拮抗剂及用途
WO2016023832A1 (en) * 2014-08-11 2016-02-18 Hydra Biosciences, Inc. Thieno- and furo[2,3-d]pyrimidine-2,4[1h,3h]-dione derivatives as trpc5 modulators for the treatment of neuropsychiatric disorders
US12006328B2 (en) * 2014-11-18 2024-06-11 Emory University Thieno[2,3-d]pyrimidin-4-one derivatives as NMDAR modulators and uses related thereto
UY36586A (es) * 2015-03-26 2016-10-31 Bayer Pharma AG Heterociclilmetiltienouracilos y uso de los mismos
AR106472A1 (es) 2015-10-26 2018-01-17 Gilead Apollo Llc Inhibidores de acc y usos de los mismos
CA3004798C (en) 2015-11-25 2023-10-31 Gilead Apollo, Llc Ester acc inhibitors and uses thereof
CA3004796C (en) 2015-11-25 2023-11-14 Gilead Apollo, Llc Pyrazole acc inhibitors and uses thereof
EA201890910A1 (ru) 2015-11-25 2018-11-30 Джилид Аполло, Ллс ФУНГИЦИДНЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 2,4-ДИОКСО-1,4-ДИГИДРОТИЕНО[2,3-d]ПИРИМИДИНА
PL3380479T3 (pl) 2015-11-25 2023-05-08 Gilead Apollo, Llc Triazolowe inhibitory acc i ich zastosowania
EP4364795A3 (en) 2016-03-02 2024-08-14 Gilead Apollo, LLC Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof
EP4122464B1 (en) 2017-03-28 2024-05-15 Gilead Sciences, Inc. Therapeutic combinations for treating liver diseases
CN121202886A (zh) * 2024-06-26 2025-12-26 浙江养生堂天然药物研究所有限公司 杂环类化合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02225485A (ja) * 1989-02-27 1990-09-07 Taiho Yakuhin Kogyo Kk チエノピリミジン―３―酢酸誘導体
US5082838A (en) * 1989-06-21 1992-01-21 Takeda Chemical Industries, Ltd. Sulfur-containing fused pyrimidine derivatives, their production and use
CA2036618C (en) * 1990-02-22 2002-10-29 Akira Morimoto Fused thiophene derivatives, their production and use
DE4008726A1 (de) * 1990-03-19 1991-09-26 Basf Ag Thieno(2,3-d)pyrimidinderivate
TW270116B (Direct) * 1991-04-25 1996-02-11 Hoffmann La Roche

Also Published As

Publication number Publication date
NO307565B1 (no) 2000-04-25
RU94030480A (ru) 1996-10-10
FI990387A7 (fi) 1999-02-23
DE69428952D1 (de) 2001-12-13
KR950005311A (ko) 1995-03-20
TW276256B (Direct) 1996-05-21
ATE208393T1 (de) 2001-11-15
CA2130859A1 (en) 1995-02-27
FI943912A0 (fi) 1994-08-25
EP0640606A1 (en) 1995-03-01
HU9402453D0 (en) 1994-10-28
DE69428952T2 (de) 2002-06-27
NO943146L (no) 1995-02-27
RU2142275C1 (ru) 1999-12-10
EP0640606B1 (en) 2001-11-07
FI943912A7 (fi) 1995-06-05
FI990387A0 (fi) 1999-02-23
CN1106663A (zh) 1995-08-16
NO943146D0 (no) 1994-08-25
HUT71116A (en) 1995-11-28
FI943912L (fi) 1995-06-05

Similar Documents

Publication Publication Date Title
HU218939B (hu) 2,4-Dioxo-tieno[2,3-d]pirimidin-származékok, eljárás a vegyületek előállítására, valamint ezeket tartalmazó gyógyászati készítmények
AU2002336172B2 (en) Bicyclic oxopyridine and oxopyrimidine derivatives
CA2409743C (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
US5389641A (en) Fused heterocyclic compounds, having angiotensin II antagonistic activity
JP7575952B2 (ja) １５－ｐｇｄｈ阻害薬
AU2008310874B2 (en) Heterocyclic compounds as CRTH2 receptor antagonists
CA2733247C (en) Heterocyclic amide derivatives as ep4 receptor antagonists
AU2003252990B2 (en) Bicyclic heteroaromatic compounds as kinase inhibitors
AU745081B2 (en) Sulfonamide compounds and medicinal use thereof
AU2003253087B2 (en) Arylamine substututed bicyclic heteroaromatic compounds as P38 kinase inhibitors
US6174884B1 (en) 1,5-dihydro-pyrazolo[34-D]-pyrimidinone derivatives
WO2020160151A1 (en) 15-pgdh inhibitors
JPH0717637B2 (ja) 置換チオフェン又はフランを組みこんだアンギオテンシンｉｉ拮抗薬
SK11772002A3 (sk) Pyrimidín-4-ónové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
KR20070042164A (ko) 피라졸로피리딘 유도체
MXPA05011103A (es) Compuestos de quinazolina.
WO1999051605A1 (en) PYRROLO[1,2-a]PYRAZINE sPLA2 INHIBITOR
US7795256B2 (en) Thieno-pyridinone derivatives as kinase inhibitors
EP0846119B1 (en) Thienopyrimidine derivatives, their production and use as endothelin antagonists
US6140325A (en) Thienopyrimidine derivatives, their production and use
CN117964639A (zh) 一种含苯并杂环结构的哒嗪类化合物、其药物组合物和用途
JPH03220189A (ja) キノリン化合物

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee